DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag
Future Sci OA
.
2017 Nov 3;4(2):FSO265.
doi: 10.4155/fsoa-2017-0120.
eCollection 2018 Feb.
Authors
Cristina Bagacean
1
2
3
4
1
2
3
4
,
Mihnea Zdrenghea
4
4
,
Christelle Le Dantec
1
2
1
2
,
Adrian Tempescul
1
2
5
1
2
5
,
Christian Berthou
1
2
5
1
2
5
,
Yves Renaudineau
1
2
3
1
2
3
Affiliations
1
U1227 B Llymphocytes & Autoimmunity, University of Brest, INSERM, IBSAM, Brest, France.
2
Labex IGO, Networks IC-CGO & REpiCGO from 'Canceropole Grand Ouest', Brest, France.
3
Laboratory of Immunology & Immunotherapy, Brest University Medical School Hospital, Brest, France.
4
'Iuliu Hatieganu' University of Medicine & Pharmacy, Cluj-Napoca, Romania.
5
Department of Hematology, Brest University Medical School Hospital, Brest, France.
PMID:
29379639
PMCID:
PMC5778384
DOI:
10.4155/fsoa-2017-0120
No abstract available
Keywords:
DNA hydroxymethylation; DNA methylation; DNMT; TET; chronic lymphocytic leukemia.
Publication types
Editorial